Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid.

Related Articles

Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid.
Cancer Biother Radiopharm. 2009 Aug;24(4):469-75
Authors: Coleman RE, Stubbs JB, Barrett JA, de la Guardia M, Lafrance N, Babich JW
This is a first of many phase 1 study of Ultratrace Iobenguane I-131 (Ultratrace 131I-MIBG; Molecular Insight Pharmaceuticals, Inc., […]

Investigation of actual condition of management and disposal of medical radioactive waste in Korea.

Investigation of actual condition of management and disposal of medical radioactive waste in Korea.
Nippon Hoshasen Gijutsu Gakkai Zasshi. 2009 Jul 20;65(7):952-7
Authors: Watanabe H, Nagaoka H, Yamaguchi I, Horiuchi S, Imoto A
In order to realize the rational management and disposal of radioactive waste like DIS or its clearance as performed in Europe, North America, and […]

 

Advertise here for free